CANDRIAM S.C.A. – Revolution Medicines, Inc. Transaction History
CANDRIAM S.C.A. portfolio value:
$14.44M
portfolio value
CANDRIAM S.C.A. quarter portfolio value change:
+1.18%
quarter
Revolution Medicines, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +31.93% | 177.26K shares | 3.62M | $19.72 | 732.50K |
| Q2 2022 | share | Increase | +27.88% | 121.05K shares | -255K | $19.49 | 555.23K |
| Q1 2022 | share | Decrease | -3.59% | -16.17K shares | -260K | $25.51 | 434.18K |
| Q4 2021 | share | Decrease | -7.97% | -39K shares | -2.12M | $25.59 | 450.36K |
| Q3 2021 | share | Increase | +24.19% | 95.30K shares | 955K | $27.51 | 489.36K |
| Q2 2021 | share | Increase | 0.00% | 394.05K shares | 12.50M | $31.74 | 394.05K |